Natco Pharma Ltd

  • BSE Code : 524816
  • NSE Symbol : NATCOPHARM
  • ISIN : INE987B01026
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 892.90 8.60(0.97%)

Open Price ()

893.10

Prev. Close ()

884.30

Volume (No’s)

946,391

Market Cap ()

15,992.72

Low Price ()

884.80

High Price ()

913.40

 

Corporate Announcement

04-Jun-2026 Natco Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
03-Jun-2026 Natco Pharma Limited - Press Release
29-Apr-2026 Natco Pharma Limited - Disclosure under SEBI Takeover Regulations
25-Mar-2026 Natco Pharma Limited - Shareholders meeting
24-Mar-2026 Natco Pharma Limited - Outcome of Board Meeting

Stock Summary

Market Cap(₹Cr.)

15,993.62

P/E (TTM)

12.48

Book value ()

477.51

Div Yield (%)

0.56

EPS (TTM)

71.55

Face Value ()

2.00

Technical Analysis

Key Level

Resistance 1

891.27

Resistance 2

898.23

Support 1

878.87

Support 2

873.43

Moving Average

30 Days

1,004.46

50 Days

1,046.07

100 Days

988.80

200 Days

924.36

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Natco Pharma Ltd 15,993.62 12.48 1.95 2465.6 0.56 71.55
Sun Pharmaceutical Indust.. 448,147.79 149.3 17.11 7162.05 0.86 12.51
Divis Laboratories Ltd 179,009.45 67.24 10.27 3332 0.44 100.29
Torrent Pharmaceuticals L.. 152,779.35 69.06 16.9 4001.11 0.84 65.37
Cipla Ltd 115,772.31 33.63 2.89 5313.67 0.91 42.61

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 34151707 19.07
Total Institutions 9774421 5.46
Total Govt Holding 1176 0.00
Total Non Promoter Corporate Holding 2444856 1.37
Total Promoters 88515126 49.42
Total Public & others 44222584 24.69
Total 179109870 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company as 'Natco Fine Pharmaceuticals Private Limited'. The name of the company was changed to Natco Pharma Limited and a fresh certificate of incorporation dated 30 December 1994 issued by the RoC, Andhra Pradesh.

Natco Pharma is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and complex products. It sells products in over 40 countries. FDF products are sold in the United States, India, Europe and the rest of the world (RoW). Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides.

In 1988, the company inaugurated a Parenterals manufacturing facility at Nagarajuna Sagar, Telangana. In 1993, the company inaugurated its chemical division at Mekaguda, Telangana. On 1 April 1995...

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew